Clinical study on abdominal acupuncture in the treatment of heart and kidney yang deficiency syndrome of heart failure

INTERVENTION: DZ01ZL01 The Control Group(Conventional drug therapy):Conventional drug therapy (valsartan + metoprolol succinate + spironolactone + Furosemide);The Treatment Group(Conventional drug therapy + abdominal acupuncture):Conventional drug therapy (valsartan + metoprolol succinate + spironolactone + Furosemide)+ abdominal acupuncture; CONDITION: heart failure PRIMARY OUTCOME: NYHA Heart Function; SECONDARY OUTCOME: 6 minute walk test;NT‐proBNP;TCM syndrome integration;C‐MLHFQ; INCLUSION CRITERIA: (1) Patients with newly diagnosed chronic heart failure or previously diagnosed heart failure who are currently under drug control; (2) NYHA cardiac function class ?‐?; (3) Sign the informed consent and volunteer to participate in the research project; (4) Persons aged between 18 and 80.